PIKFYVE and autoimmune disease: An important enzyme involved in vesicle trafficking, phosphatidylinositol-3-phosphate 5-kinase type III (PIKfyve), has shown to be a promising in vitro therapeutic target for multiple diseases, including cancers, autoimmune diseases, and emerging viral diseases14–20.